Statements (85)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired |
gptkb:Zy_Co_V-D_vaccine
Novartis Animal Health in 2014 |
| gptkbp:acquisition |
gptkb:Boehringer_Ingelheim's_animal_health_business
|
| gptkbp:acquisition_year |
gptkb:2020
|
| gptkbp:awards |
Best Places to Work
Innovation Awards Sustainability Awards |
| gptkbp:categories |
Antibiotics
Vaccines Diagnostics Nutritional products Parasiticides |
| gptkbp:ceo |
gptkb:Jeff_Simmons
|
| gptkbp:collaborations |
Government agencies
Agricultural organizations Veterinary associations |
| gptkbp:community_engagement |
Veterinary education support
|
| gptkbp:employees |
Approximately 5,000
|
| gptkbp:employs |
over 3,000 people
|
| gptkbp:financial_performance |
Publicly traded
Annual reports available Quarterly earnings reports available |
| gptkbp:focus |
Pet health and livestock health
|
| gptkbp:focuses_on |
animal welfare
|
| gptkbp:founded |
gptkb:1954
|
| gptkbp:founder |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:global_presence |
Operations in over 90 countries.
|
| gptkbp:has_a_focus_on |
innovation
|
| gptkbp:has_a_presence_in |
gptkb:North_America
over 90 countries |
| gptkbp:has_diversity_initiatives |
therapeutics for pets
|
| gptkbp:has_history |
expanding through acquisitions
|
| gptkbp:has_partnerships_with |
veterinary schools
|
| gptkbp:has_research_center |
gptkb:Indiana
|
| gptkbp:headcount |
5,000+
|
| gptkbp:headquartered_in |
Greenfield
|
| gptkbp:headquarters |
gptkb:Greenfield,_Indiana,_USA
|
| https://www.w3.org/2000/01/rdf-schema#label |
Elanco Animal Health
|
| gptkbp:industry |
Animal Health
|
| gptkbp:is_a_global_leader_in |
animal health products
|
| gptkbp:is_committed_to |
animal health education
|
| gptkbp:is_displayed_in |
gptkb:New_York_Stock_Exchange
|
| gptkbp:is_involved_in |
genetic research
|
| gptkbp:is_known_for |
pet vaccines
|
| gptkbp:market |
Global
|
| gptkbp:mission |
Enhancing the health of animals and the people who care for them.
|
| gptkbp:offers |
vaccines
|
| gptkbp:operates_in |
animal health
pet health |
| gptkbp:parent_company |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:partnership |
Various veterinary schools
|
| gptkbp:partnerships |
gptkb:Non-profit_organizations
Research institutions Veterinary clinics |
| gptkbp:philanthropy |
Disaster relief efforts
Community health programs Animal welfare initiatives |
| gptkbp:produces |
medications for livestock
|
| gptkbp:products |
Veterinary pharmaceuticals
|
| gptkbp:provides |
animal health products
|
| gptkbp:research_and_development |
Animal health innovations
|
| gptkbp:research_focus |
Antimicrobial resistance
Animal nutrition Animal behavior Vaccination strategies Genetics in livestock |
| gptkbp:revenue |
$1.5 billion (2020)
|
| gptkbp:services |
Animal health products
|
| gptkbp:social_responsibility |
gptkb:Community_development
Environmental sustainability Animal welfare advocacy |
| gptkbp:stock_symbol |
gptkb:ELAN
|
| gptkbp:strategic_goals |
Increase market share
Enhance customer engagement Invest in technology Expand product portfolio Strengthen global presence |
| gptkbp:subsidiary |
gptkb:Elanco_US_Inc.
|
| gptkbp:sustainability_initiatives |
Animal welfare programs
|
| gptkbp:traded_on |
gptkb:New_York_Stock_Exchange
|
| gptkbp:vision |
A world where animals are healthy and people are happy.
|
| gptkbp:website |
www.elanco.com
|
| gptkbp:bfsParent |
gptkb:Eli_Lilly
|
| gptkbp:bfsLayer |
4
|